Moreover, the recently published study by Gorham et al. [67], which assessed the outcome of patients with IL-6 levels measured repeatedly during COVID-19 in patients admitted to the ICU, found much higher levels, like those in patients with hypoinflammatory ARDS [66]. The gene discussed is IL6; the disease is COVID-19.